FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

331829005: Betamethasone+salicylic acid 0.05/3% scalp application (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    468564013 Betamethasone+salicylic acid 0.05/3% scalp application en Synonym Active Entire term case insensitive SNOMED CT core module
    1192589010 Betamethasone+salicylic acid 0.05/3% scalp application (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    46767301000001118 Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module
    60116201000001116 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Betamethasone+salicylic acid 0.05/3% scalp application Is a Product containing betamethasone and salicylic acid false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Adrenal hormone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Corticosterone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Adrenal hormone agent false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Keratolytic agent false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Topical agent false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Is a Product containing salicylic acid in topical dosage form false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form Liquid false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has specific active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has specific active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has dispensed dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has basis of strength substance Betamethasone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Betamethasone+salicylic acid 0.05/3% scalp application - product Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Is pack of False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (PI) (Waymade Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Dowelhurst Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Sigma Pharmaceuticals Plc) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has VMP False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Lexon (UK) Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Mawdsley-Brooks & Company Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Necessity Supplies Ltd) Is a False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has VMP False Betamethasone+salicylic acid 0.05/3% scalp application Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start